Clinical Trials

Can Nanofiber Vaccines Revolutionize Alzheimer's and Dementia Treatment?
Research & Development Can Nanofiber Vaccines Revolutionize Alzheimer's and Dementia Treatment?

Imagine a world where Alzheimer's disease and frontotemporal dementia could be combated not with costly and sometimes harmful treatments, but with vaccines specially designed to target specific proteins without causing inflammation. This innovative approach is currently being explored by

Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes
Research & Development Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes

In a groundbreaking study from Karolinska Institutet in Sweden, researchers have introduced an innovative method aimed at concurrently screening for liver fibrosis and eye disease in people living with type 2 diabetes. By combining liver damage screening with the already established retina scanning

AI Model Enhances Early Detection of Pancreatic Ductal Adenocarcinoma
Tech & Innovation AI Model Enhances Early Detection of Pancreatic Ductal Adenocarcinoma

In a groundbreaking development for cancer diagnostics, researchers at the University of British Columbia have created an innovative deep learning model aimed at improving the diagnosis and treatment of pancreatic ductal adenocarcinoma (PDAC). This type of pancreatic cancer is notably the most

Can mTOR Inhibitors Treat Rare Genetic Immunodeficiency Disorders?
Research & Development Can mTOR Inhibitors Treat Rare Genetic Immunodeficiency Disorders?

Genetic mutations causing rare immunodeficiency disorders present significant challenges to medical science, but recent advancements offer hope to affected individuals. University of Surrey researchers have made promising strides in understanding and potentially treating these conditions,

Can Real-Time Sensors Revolutionize Bone Injury Recovery?
Tech & Innovation Can Real-Time Sensors Revolutionize Bone Injury Recovery?

The use of miniature implantable sensors in the field of bone injury recovery could mark a groundbreaking turn in medical advancements, as demonstrated by researchers at the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact. Developed through the collaborative

Can Cell-Penetrating Antibodies Revolutionize Cancer Treatment?
Research & Development Can Cell-Penetrating Antibodies Revolutionize Cancer Treatment?

Recent advancements in the field of monoclonal antibody (mAb) treatments have shown a promising shift towards more effective cancer therapies. The 3E10 antibody, initially identified in autoimmune mouse studies focused on systemic lupus erythematosus, has emerged as a game-changer. Unlike

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later